Navigation Links
Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting

reater than 10 month survival criteria.

Definitive Phase III data regarding the use of ERBITUX in 1st line NSCLC are expected to be available later this year from two large randomized trials (FLEX and BMS-099) that have enrolled approximately 1800 patients.

Pancreatic Cancer

In pancreatic cancer, a notoriously difficult-to-treat cancer, the Phase III SWOG S0205 trial did not meet its primary end point. On-going trials are continuing to investigate additional combinations of ERBITUX with chemotherapy and biologics in patients with this aggressive cancer for whom treatment options remain acutely limited.

Other ERBITUX data presented at ASCO included the following:

-- Two randomized studies evaluated ERBITUX combined with oxaliplatin-based chemotherapy in first line mCRC. OPUS, a randomized Phase II study, demonstrated approximately a 10% improvement in response rate (45.6% vs 35.7%) compared to chemotherapy alone. This difference, however, was not statistically significant. However, for a subgroup of patients with an ECOG performance status of 0 and 1 the response rate was statistically in favor of the ERBITUX/FOLFOX combination. COIN, a randomized Phase III study, showed that ERBITUX can be safely combined with three different oxaliplatin regimens.

-- The feasibility of ERBITUX administration at 500 mg/m2 every 2 weeks as 60 minute infusion was reported in mCRC patients with refractory disease. This data corroborates previous findings suggesting that ERBITUX may be administered every two weeks.

-- In vitro data confirmed that ERBITUX, an IgGI monoclonal antibody, induces antibody-dependent cellular cytotoxicity (ADCC) in contrast to the lack of such activity in IgG2 monoclonal antibodies.

-- Erbitux plus radiation is currently a standard of care for patients with locally advanced Head and Neck cancer. The Eastern Cooperative Oncology Group reported promising results of a Phase II neoadjuvant study evaluating ind
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Extensive Clinical Data Erbitux Presented the ASCO Annual Meeting
(Date:8/27/2014)... Aug. 27, 2014  Decision Resources Group finds ... oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and nephrology) expect ... a biosimilar has been assessed in to be ... choose to prescribe. Other key ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... 2014   Los Angeles orthodontics expert, Dr. ... patients who want to make their treatment even faster. ... OrthoSpaceship, all patients have a powerful tool to use ... be used by most patients with all types of ... using the AcceleDent® Aura system for a few minutes ...
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
(Date:8/27/2014)... Denver (PRWEB) August 27, 2014 NexCore ... has broken ground on a 79,491 square foot medical ... hospital campus in Germantown, an unincorporated municipality located approximately ... third most populous place in Maryland, after Baltimore and ... Cross Germantown Hospital campus is one of three outpatient ...
(Date:8/27/2014)... 2014 Georgia State University’s Center ... two-year, $600,000 grant from the Maternal and Child ... Administration to support implementation of the Autism Plan ... and youth with autism spectrum disorder. , In ... Autism Advisory Council composed of key stakeholders from ...
(Date:8/27/2014)... PA (PRWEB) August 27, 2014 Dr. ... Inc. , a leader in promoting better health outcomes ... the addition of Ms. Maura Connor to the executive ... Publishing, Editor-in-Chief, Ms. Connor will be responsible for providing ... of digital products and content across all markets. ...
(Date:8/27/2014)... With most forms of hearing ... use hearing protection when exposed to loud noises ... different forms of hearing protection for ... protection training and devices for workers in construction, ... National Institute of Occupational Safety and Health (NIOSH) ...
(Date:8/27/2014)... Orange, NJ. August 27, 2014. Kessler Foundation scientists ... competence in brain injury research and rehabilitation. The ... PhD: Issues of cultural diversity in acquired brain ... Neurorehabilitation . Drs. Lequerica and Krch ... Research at Kessler Foundation and co-investigators for the ...
Breaking Medicine News(10 mins):Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 3
... , , , WASHINGTON, July ... Americans are wary of health reform legislation will be released at ... Wednesday, July 15, in the Murrow Room, 13th floor, National Press ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080917/NPCLOGO ) , ...
... in a purr, exploits human psyche, researchers say, , MONDAY, July ... up on the bed and, as he does every morning, lets ... is irresistible: Get up now and feed me. , A new ... Socks -- suggests that smart housecats quickly learn that this ...
... , , MEMPHIS, Tenn., ... Children,s Research Hospital, has been invited to give the 2010 Leeuwenhoek ... , The Leeuwenhoek Lecture, named after microscopist Antony ... microbiology. Webster will present the lecture next summer. The Royal Society, ...
... , WASHINGTON, July 13 The American ... specialists, will honor six scientists who have made significant contributions to ... Ernest Beutler Lecture and Prize, will be presented at the 51st ... , , Past ASH president ...
... to spotting disease, study finds , MONDAY, July 13 ... is an important factor in early diagnosis of the ... cure for Alzheimer,s disease, some doctors don,t put much ... the wrong outlook, said Dr. Nerida Paterson, senior lecturer ...
... first time in more than 10 years, the universally accepted ... reflect the prognosis for patients with non-small cell lung cancer ... of CHEST , the peer-reviewed journal of the American ... recommendations of the International Staging Committee of the International Association ...
Cached Medicine News:Health News:Cats Purrfect at Getting Needs Met, Study Shows 2Health News:Cats Purrfect at Getting Needs Met, Study Shows 3Health News:St. Jude Virologist Honored by the Royal Society 2Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 2Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 3Health News:Doctors' Attitudes Play Part in Early Alzheimer's Diagnosis 2Health News:New lung cancer staging system revealed 2Health News:New lung cancer staging system revealed 3
... two and four ounce bottles ... the needs of procedural kit ... itself has been custom molded ... the cap perfectly. This product ...
A patient skin prepping solution in a self-contained applicator combining two proven broad-spectrum antimicrobials: alcohol for fast kill and fast drying (3 minutes on skin), and an iodophor for pers...
Idophor PVP Scrub Winged Sponges...
... can be a valuable tool in standardizing ... items necessary for a procedure are supplied ... continuum of care are easier to be ... sequence of use, allowing the clinician to ...
Medicine Products: